Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;43(5):895-904.
doi: 10.1007/s10096-024-04803-0. Epub 2024 Mar 12.

Human Campylobacter spp. infections in Italy

Affiliations
Free article

Human Campylobacter spp. infections in Italy

Verena Zerbato et al. Eur J Clin Microbiol Infect Dis. 2024 May.
Free article

Abstract

Purpose: Campylobacter is a frequent cause of enteric infections with common antimicrobial resistance issues. The most recent reports of campylobacteriosis in Italy include data from 2013 to 2016. We aimed to provide national epidemiological and microbiological data on human Campylobacter infections in Italy during the period 2017-2021.

Methods: Data was collected from 19 Hospitals in 13 Italian Regions. Bacterial identification was performed by mass spectrometry. Antibiograms were determined with Etest or Kirby-Bauer (EUCAST criteria).

Results: In total, 5419 isolations of Campylobacter spp. were performed. The most common species were C. jejuni (n = 4535, 83.7%), followed by C. coli (n = 732, 13.5%) and C. fetus (n = 34, 0.6%). The mean age of patients was 34.61 years and 57.1% were males. Outpatients accounted for 54% of the cases detected. Campylobacter were isolated from faeces in 97.3% of cases and in 2.7% from blood. C. fetus was mostly isolated from blood (88.2% of cases). We tested for antimicrobial susceptibility 4627 isolates (85.4%). Resistance to ciprofloxacin and tetracyclines was 75.5% and 54.8%, respectively; resistance to erythromycin was 4.8%; clarithromycin 2% and azithromycin 2%. 50% of C. jejuni and C. coli were resistant to ≥ 2 antibiotics. Over the study period, resistance to ciprofloxacin and tetracyclines significantly decreased (p < 0.005), while resistance to macrolides remained stable.

Conclusion: Campylobacter resistance to fluoroquinolones and tetracyclines in Italy is decreasing but is still high, while macrolides retain good activity.

Keywords: Campylobacter jejuni; (6): Campylobacter spp; Antimicrobial resistance; Italy; Multidrug-resistant; Surveillance.

PubMed Disclaimer

References

References:

    1. Campylobacter FC (2015) Clin Lab Med 35(2):289–298. https://doi.org/10.1016/j.cll.2015.03.001 - DOI
    1. Rukambile E, Sintchenko V, Muscatello G, Kock R, Alders R (2019) Infection, colonization and shedding of Campylobacter and Salmonella in animals and their contribution to human disease: A review. Zoonoses Public Health 66(6):562–578. https://doi.org/10.1111/zph.12611 - DOI - PubMed
    1. Costa D, Iraola G (2019) Pathogenomics of Emerging Species. Clin Microbiol Rev. 32(4). https://doi.org/10.1128/CMR.00072-18
    1. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM (2015) Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev 28(3):687–720. https://doi.org/10.1128/CMR.00006-15 - DOI - PubMed - PMC
    1. European Food Safety Authority, European Centre for Disease Prevention and Control (2022) The European Union One Health 2021 Zoonoses Report. EFSA J 20(12):e07666. https://doi.org/10.2903/j.efsa.2022.7666

MeSH terms